Dudediligence.

Harrow, Inc

HROWNASDAQ · Pharmaceutical Preparations
Write an idea

Insiders

Last 12 months

Sales planned on beside the trades reported on , and whether each names a .

Planned ·

$450,000

1 notice · 11,250 sh

Oct 2025 to Oct 2026

Reported ·

$9,183,891

6 sales · 4 buys · $468,720 bought

Oct 2025 to Jun 2026

The two figures cover different periods.

None of the 6 reported sales carry the 10b5-1 box. Together they are 0.60% of the shares on issue.

PLANNED · FORM 144Oct 2025 to Oct 2026REPORTED · FORM 4Oct 2025 to Jun 2026N2025DJ2026FMAMJJASO2026-08-14: AMIR SHOJAEI, Form 1442026-01-06: Opaleye Management Inc., sold2026-02-27: Opaleye Management Inc., sold2026-03-03: Opaleye Management Inc., sold2026-05-14: BOLL ANDREW R., bought2026-05-14: BAUM MARK L, bought2026-05-18: SILVERNAIL LAUREN P, bought2026-05-18: Graves Adrienne L, bought
under a no plan named▼ sale▲ buysize is dollars

Form 144 notices, newest first

2026-08-14AMIR SHOJAEI, CHIEF SCIENTIFIC OFFICER$450,000
11,250 shno plan dateForm 4s on file end Jun 23144 ↗